Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance/metadata update rather than a change to core study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:59:03.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the study record. This change is administrative and does not alter the study details or participant-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T10:41:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Footer area now includes new institutional attributions for the Moffitt Cancer Center Clinical Trials website and related entities, and the revision tag in the footer has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-03T22:53:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a recent deployment of the ClinicalTrials.gov page. This update does not change the study details or any data presented on the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:21:35.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Page now displays a recruitment status indicating no longer looking for participants and adds new reader guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to help users understand and engage with the study. The Intervention/Treatment label is reformatted, and the site revision is updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T15:37:29.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a new published iteration of the page.
    Difference
    0.1%
    Check dated 2026-06-05T11:21:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.